Proteomic Investigations into Hemodialysis Therapy

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
acute kidney injury 1 nephrologydiseases
chronic kidney disease 1 nephrologydiseases
kidney failure 1 nephrologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
acute kidney injury 25066 and A1AG1 (representative uremic retention solutes), NGAL (one of the most promising biomarkers of acute kidney injury and a stress marker in chronic dialysis), zinc-α2 glycoproteìn, transferrin and complement factor
chronic kidney disease 15215 molecule is considered the most promising protein-bound uremic toxin as a biomarker of progress in chronic kidney disease (CKD). More recently, plasma proteome of CKD stage 2–3 patients and CKD stage 5 patients on HD was
kidney failure 2429 systemic poisoning [[1]], characterized by a variety of clinical symptoms that develop and worsen as kidney failure proceeds, due to the retention of various solutes, which are normally excreted by the kidney, called

You must be authorized to submit a review.